PROCEPT BioRobotics Corp. (PRCT)
19.96
-0.07
(-0.35%)
USD |
NASDAQ |
Oct 23, 16:00
19.95
-0.01
(-0.05%)
After-Hours: 20:00
PROCEPT BioRobotics Enterprise Value : 992.24M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 992.24M |
| October 22, 2026 | 996.24M |
| October 21, 2026 | 895.49M |
| October 20, 2026 | 926.97M |
| October 19, 2026 | 896.06M |
| October 16, 2026 | 855.42M |
| October 15, 2026 | 888.62M |
| October 14, 2026 | 851.98M |
| October 13, 2026 | 943.00M |
| October 12, 2026 | 969.91M |
| October 09, 2026 | 902.93M |
| October 08, 2026 | 874.31M |
| October 07, 2026 | 874.88M |
| October 06, 2026 | 851.98M |
| October 05, 2026 | 869.73M |
| October 02, 2026 | 831.94M |
| October 01, 2026 | 823.93M |
| September 30, 2026 | 892.63M |
| September 29, 2026 | 892.63M |
| September 28, 2026 | 837.10M |
| September 25, 2026 | 834.23M |
| September 24, 2026 | 851.41M |
| September 23, 2026 | 885.18M |
| September 22, 2026 | 904.65M |
| September 21, 2026 | 909.23M |
| Date | Value |
|---|---|
| September 18, 2026 | 954.45M |
| September 17, 2026 | 964.19M |
| September 16, 2026 | 962.47M |
| September 15, 2026 | 954.45M |
| September 14, 2026 | 1.053B |
| September 11, 2026 | 1.016B |
| September 10, 2026 | 998.53M |
| September 09, 2026 | 1.037B |
| September 08, 2026 | 1.072B |
| September 04, 2026 | 1.153B |
| September 03, 2026 | 1.073B |
| September 02, 2026 | 1.107B |
| September 01, 2026 | 1.047B |
| August 31, 2026 | 1.063B |
| August 28, 2026 | 1.042B |
| August 27, 2026 | 1.029B |
| August 26, 2026 | 1.056B |
| August 25, 2026 | 1.086B |
| August 24, 2026 | 1.066B |
| August 21, 2026 | 1.091B |
| August 20, 2026 | 1.036B |
| August 19, 2026 | 1.104B |
| August 18, 2026 | 1.070B |
| August 17, 2026 | 1.057B |
| August 14, 2026 | 1.089B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Insulet Corp. | 10.75B |
| Abbott Laboratories | 207.10B |
| Baxter International, Inc. | 19.76B |
| Becton, Dickinson & Co. | 70.12B |
| Boston Scientific Corp. | 78.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.86M |
| Revenue (Quarterly) | 94.50M |
| Total Expenses (Quarterly) | 121.36M |
| EPS Diluted (Quarterly) | -0.4707 |
| Gross Profit Margin (Quarterly) | 66.01% |
| Profit Margin (Quarterly) | -28.42% |
| Earnings Yield | -9.76% |
| Normalized Earnings Yield | -9.754 |